Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: Taiwan Clear all

184 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20034
20044
20056
20068
20075
200811
200911
201021
201120
20127
20138
201410
20159
20163
201711
20184
20199
20208
20217
20225
20236
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed184

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S29
AstraZeneca22
Eli Lilly and Company20
Boehringer Ingelheim19
Sanofi9
Chang Gung Memorial Hospital5
National Taiwan University Hospital5
Pfizer5
Bayer4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2184
Diabetes Mellitus40
Insulin Resistance6
Renal Insufficiency, Chronic6
Hyperglycemia5
Obesity5
Overweight5
Cardiovascular Diseases4
Diabetic Nephropathies4
Hypertension4

Trials

Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.

84 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.